BACKGROUND: Genomic surveillance activity is a useful tool in epidemiologic investigations and monitoring of virus evolution. This study aimed to describe the COVID-19 outbreaks through SARS-CoV-2 virus genomic surveillance by whole genome sequencing.
METHODS: A cross-sectional study was conducted using archived clinical samples of confirmed laboratory-positive COVID-19 from June 2021 to June 2022 from a tertiary center in Malaysia. The samples were subjected to whole genome sequencing. A phylogenetic tree was constructed using the maximum likelihood method in MEGA 11 software. The clinical data were obtained through paper, electronic, and hospital information systems.
RESULTS: A total of 86 clinical samples were successfully sequenced. The phylogenetic tree revealed seven clusters, consisting of 24 cases. Three clusters were associated with health care workers and health care-associated individuals. The SARS-CoV-2 Delta variants were observed in the first three clusters and subsequently replaced with the Omicron variants.
CONCLUSIONS: Whole genome sequencing is robust and reliable, enhancing epidemiologic investigations, leading to the identification of clusters and preventing the spreading of COVID-19 among health care workers. Monitoring of the SARS-CoV-2 variants is necessary to study the viral dynamics and maintain the effectiveness of public health interventions.
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.